Heterocyclic compounds as Wee1 inhibitors are provided. The compounds may find use as therapeutic agents for the treatment of diseases and may find particular use in oncology.
This disclosure relates to polycyclic heteroaromatic compounds useful as TRPA1 modulators, as well as compositions and methods of treating pain that include the compounds.
本公开涉及可用作 TRPA1 调节剂的多环杂芳族化合物,以及包含该化合物的治疗疼痛的组合物和方法。
HETEROARYL INHIBITORS OF SUMO ACTIVATING ENZYME
申请人:MILLENNIUM PHARMACEUTICALS, INC.
公开号:US20160355504A1
公开(公告)日:2016-12-08
Disclosed are compounds of formula (I); or a pharmaceutically acceptable salt thereof; wherein Y, Ra, Ra′, Rc, Rf, X2, Rd, Rd′, Re, Re′2, m, and G have the values described herein and stereochemical configurations depicted at asterisked positions indicate absolute stereochemistry, useful as inhibitors of Sumo Activating Enzyme (SAE). Further provided are pharmaceutical compositions comprising a compound of the disclosure and methods of using the compositions in the treatment of proliferative, inflammatory, cardiovascular and neurodegenerative diseases or disorders.
TRPA1 MODULATORS
申请人:Algomedix, Inc.
公开号:US20190016701A1
公开(公告)日:2019-01-17
This disclosure relates to polycyclic heteroaromatic compounds useful as TRPA1 modulators, as well as compositions and methods of treating pain that include the compounds.